| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/18/2007 | CN1310641C Method and apparatus for releasing L-ascorbic acid to derma cortex |
| 04/18/2007 | CN1310640C Pharmaceutical compositions |
| 04/17/2007 | USRE39576 Inhibitors of inducible nitric oxide synthase, as hypotensive agent, antiinflammatory agent, antiarthritic agent |
| 04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/17/2007 | USRE39574 Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
| 04/17/2007 | USRE39573 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 04/17/2007 | US7205436 Process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines |
| 04/17/2007 | US7205435 Type B botulism toxin inhibitors |
| 04/17/2007 | US7205434 Sulphonamido-substituted bridged bicycloalkyl derivatives having a substitute on the bridgehead position; nonpeptidic compounds to treat or prevent Alzheimer's Disease by modulating the processing of amyloid precursor proteins by the putative gamma-secretas to arrest the production of beta-amyloid |
| 04/17/2007 | US7205433 Crystal of amino acid ester salt and process for producing the same |
| 04/17/2007 | US7205420 Forming calcipotriol |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205413 Comprises formamide solvent; for treatment of HIV/inhibiting proteases; crystal structure; kits |
| 04/17/2007 | US7205412 Includes a colorant, a solvent and an antibiotic additive produced by binding antibiotic substance to predetermined additive via chemical reaction; improves storage stability and inhibits propagation and growth of bacteria in ink |
| 04/17/2007 | US7205411 for treatment of neuropathic pain |
| 04/17/2007 | US7205410 Heterocyclic amines used as antiemetics for prophylaxis of irritable bowel syndrome constipation, diarrhea, dyspepsia, nausea or vomiting |
| 04/17/2007 | US7205409 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomoderators |
| 04/17/2007 | US7205408 Therapy for bacteria infections in mammals |
| 04/17/2007 | US7205407 3-Substituted oxindole β3 agonists |
| 04/17/2007 | US7205405 Process for preparing 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl- 6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-one |
| 04/17/2007 | US7205403 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 04/17/2007 | US7205401 Separation of such enantiomers with non-chromatographic resin bed separations of three separation stages or less; efficiency; chiral purity |
| 04/17/2007 | US7205394 Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same |
| 04/17/2007 | US7205392 Synergistic mixture of glycoprotein and angiogenesis inhibitor |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205384 Process for preparing peptidyl heterocyclic ketone derivatives |
| 04/17/2007 | US7205336 β-secretase inhibitors |
| 04/17/2007 | US7205335 Preparation of cis-fused 3,3a,8,12b-tetrahydro-2H-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
| 04/17/2007 | US7205334 vacuolar-type (H+)-ATPase-inhibiting macrocyclic lactams belonging to the chondropsin class useful in cancer chemotherapy |
| 04/17/2007 | US7205333 Therapy for influenza virus; inhaler |
| 04/17/2007 | US7205332 Deoxoartemisinin analogs, process for their preparation, and anticancer agent comprising them |
| 04/17/2007 | US7205331 Pyrrole derivatives, for controlling plant diseases caused by fungal plant pathogens |
| 04/17/2007 | US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide |
| 04/17/2007 | US7205329 Modulators of CRTH2 activity |
| 04/17/2007 | US7205328 Aids viricide |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205326 Tyrosine inhibitor inhibitors; anticancer agents |
| 04/17/2007 | US7205325 Oxazole derivatives |
| 04/17/2007 | US7205324 IMPDH (inosine-5'-monophosphate dehydrogenase); transplant rejection and autoimmune diseases |
| 04/17/2007 | US7205323 Dipeptidyl peptidase IV inhibitors pharmaceutical compositions containing them, and process for their preparation |
| 04/17/2007 | US7205322 Thiazolidine compounds as calcium sensing receptor modulators |
| 04/17/2007 | US7205321 preventing, treating diabetes mellitus, Syndrome X, cardiovascular disease , hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis in a mammal |
| 04/17/2007 | US7205320 Such as 3-[3-(4-chlorophenyl)prop-1-yloxy]-4-methoxy-N-(3-pyridylmethyl)diphenylamine; reduced emetic side effect; neurological syndromes |
| 04/17/2007 | US7205319 N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 04/17/2007 | US7205318 Inhibitors of trypsin-like serine protease enzymes; for use as anticoagulant agents for therapy of thromboembolic disorders |
| 04/17/2007 | US7205317 Pain management |
| 04/17/2007 | US7205316 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 04/17/2007 | US7205315 Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases |
| 04/17/2007 | US7205314 Compounds for the treatment of dementia related diseases |
| 04/17/2007 | US7205313 Central nervous system disorders; analgesics; headaches |
| 04/17/2007 | US7205312 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis |
| 04/17/2007 | US7205311 Therapeutic acridone and acridine compounds |
| 04/17/2007 | US7205310 inflammatory conditions such as multiple sclerosis |
| 04/17/2007 | US7205309 Obesity therapy; administering orlistat |
| 04/17/2007 | US7205308 Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2007 | US7205307 Pyrimidines as novel openers of potassium ion channels |
| 04/17/2007 | US7205306 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 04/17/2007 | US7205305 Inhibitors of p38 |
| 04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
| 04/17/2007 | US7205303 Substituted heterocyclic compounds |
| 04/17/2007 | US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders |
| 04/17/2007 | US7205300 Aryl fused azapolycyclic compounds |
| 04/17/2007 | US7205299 Indole derivatives having an apoptosis-inducing effect |
| 04/17/2007 | US7205298 Substituted triazine kinase inhibitors |
| 04/17/2007 | US7205297 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| 04/17/2007 | US7205296 Substituted 2H-1,3-benzoxazin-4(3H)-ones |
| 04/17/2007 | US7205295 such as 4-(4-tert-Butyl-benzyl)-6-(4-oxo-2-thioxo-thiazolidin-5-ylidenemethyl)-4H-1,4-benzoxazin-3-one; phosphoinositide-3-kinases (PI3Ks); for treatment/prevention of inflammatory diseases, cardiovascular diseases, and cancers |
| 04/17/2007 | US7205294 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions |
| 04/17/2007 | US7205293 Benodiazepine spirohydantoin CGRP receptor antagonists |
| 04/17/2007 | US7205292 Piperidines containing a lactam ring and a quinolinone, benzimidazolone, quinazolinone or benzodiazepinone group, e.g. N-[3R,7R)-1-(Cyclopropylmethyl)-2-oxo-7-phenylazepan-3-yl]-4-(2-oxo-1,4-dihydroquinazolin-3 (2H-yl)piperidine-1-carboxamide; treating headaches, migraine headaches and cluster headaches |
| 04/17/2007 | US7205291 Carbapenem compounds |
| 04/17/2007 | US7205290 Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use |
| 04/17/2007 | US7205289 cyclic ketoenols and other known insecticidally active compounds; for controlling animal pests such as insects and undesired acarids |
| 04/17/2007 | US7205288 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 04/17/2007 | US7205287 Platinum complexes having antitumor activity |
| 04/17/2007 | US7205286 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 04/17/2007 | US7205285 Fully synthetic cyclic acyl phosphate and phosphonate mixed anhydrides are irreversible beta-lactamase inhibitors; may be used for bacterial antibiotic resistant infections and may be mixed with a beta-lactam antibiotic |
| 04/17/2007 | US7205284 Potent immunostimulants from microalgae |
| 04/17/2007 | US7205283 Antisense oligonucleotides that inhibit expression of HIF-1 |
| 04/17/2007 | US7205282 Remedies for hepatitis |
| 04/17/2007 | US7205280 Methods of suppressing microglial activation |
| 04/17/2007 | US7205279 Pharmaceutical compositions |
| 04/17/2007 | US7205275 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/17/2007 | US7205151 Antiinflammatory agents; skin disorders |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | US7205134 Δ4-desaturase genes and uses thereof |
| 04/17/2007 | US7205127 Methods of treating insulin resistance with an inhibitor of an NAD(P)H oxidase |
| 04/17/2007 | US7205126 Made by disrupting HPV-virus-like particles including a chelating agent, mixing them with plasmids and reassembling them into the pseudoviruses (VLPs with plasmids inside) adding a stop buffer to reassemble the VLPs into pseudoviruses; administering to the mucosa; can be applied in gene therapy |
| 04/17/2007 | US7205108 Trp8, Trp9 and Trp10, novel markers for cancer |
| 04/17/2007 | US7205107 CATT-tetranucleotide repeat polymorphism at position-817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays |
| 04/17/2007 | US7205006 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
| 04/17/2007 | US7205005 Comprises a flavones extract and polysaccharides |
| 04/17/2007 | US7205003 Method and topical formulation for treating skin conditions associated with aging |
| 04/17/2007 | US7205002 For causing a cell to die, for reducing intracellular glutathione, and sensitizing a cell to cytotoxic agents that the cell is resistant to due to the presence of intracellular glutathione |
| 04/17/2007 | US7205001 Anticancer agents; using potassium arsenite therapy and radiation |
| 04/17/2007 | US7204996 Method of cancer treatment |
| 04/17/2007 | US7204995 For therapy of dry eye |
| 04/17/2007 | US7204975 Cosmetic and dermatological light-protective formulations with a content of particulate UV-filter substances and alkylnaphthalates |
| 04/17/2007 | US7204974 Containing as a stabilizer a di(C 6-24 branched or unbranched alkyl) 2,6-naphthalenedicarboxylate and a lipid with a polarity of at most 30 mN/m. and its use in cosmetic or dermatological formulations.. |
| 04/17/2007 | US7204973 Cosmetic and dermatological light protection formulations with a content of hydroxybenzophenones and alkylnaphthalates |